BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22502740)

  • 21. Previous Exposure to Statin May Reduce the Risk of Subsequent Non-Hodgkin Lymphoma: A Nationwide Population-Based Case-Control Study.
    Cho SF; Yang YH; Liu YC; Hsiao HH; Huang CT; Wu CH; Tsai YF; Wang HC; Liu TC
    PLoS One; 2015; 10(10):e0139289. PubMed ID: 26425850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term use of statins and risk of colorectal cancer: a population-based study.
    Singh H; Mahmud SM; Turner D; Xue L; Demers AA; Bernstein CN
    Am J Gastroenterol; 2009 Dec; 104(12):3015-23. PubMed ID: 19809413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does statin therapy decrease the risk for bleeding in patients who are receiving warfarin?
    Douketis JD; Melo M; Bell CM; Mamdani MM
    Am J Med; 2007 Apr; 120(4):369.e9-369.e14. PubMed ID: 17398234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperlipidaemia, statin use and the risk of developing rheumatoid arthritis.
    Jick SS; Choi H; Li L; McInnes IB; Sattar N
    Ann Rheum Dis; 2009 Apr; 68(4):546-51. PubMed ID: 18662929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statins and risk of cancer: a retrospective cohort analysis of 45,857 matched pairs from an electronic medical records database of 11 million adult Americans.
    Marelli C; Gunnarsson C; Ross S; Haas S; Stroup DF; Cload P; Clopton P; DeMaria AN
    J Am Coll Cardiol; 2011 Jul; 58(5):530-7. PubMed ID: 21777752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statins reduce the risk of pancreatic cancer in humans: a case-control study of half a million veterans.
    Khurana V; Sheth A; Caldito G; Barkin JS
    Pancreas; 2007 Mar; 34(2):260-5. PubMed ID: 17312467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statin use and breast cancer: prospective results from the Women's Health Initiative.
    Cauley JA; McTiernan A; Rodabough RJ; LaCroix A; Bauer DC; Margolis KL; Paskett ED; Vitolins MZ; Furberg CD; Chlebowski RT;
    J Natl Cancer Inst; 2006 May; 98(10):700-7. PubMed ID: 16705124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statin and statin-fibrate use was significantly associated with increased myositis risk in a managed care population.
    McClure DL; Valuck RJ; Glanz M; Murphy JR; Hokanson JE
    J Clin Epidemiol; 2007 Aug; 60(8):812-8. PubMed ID: 17606177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statin use and risk of prostate cancer: a Danish population-based case-control study, 1997-2010.
    Jespersen CG; Nørgaard M; Friis S; Skriver C; Borre M
    Cancer Epidemiol; 2014 Feb; 38(1):42-7. PubMed ID: 24275259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The risk of cancer in users of statins.
    Graaf MR; Beiderbeck AB; Egberts AC; Richel DJ; Guchelaar HJ
    J Clin Oncol; 2004 Jun; 22(12):2388-94. PubMed ID: 15197200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The risk of myopathy associated with thiazolidinediones and statins in patients with type 2 diabetes: a nested case-control analysis.
    Koro CE; Sowell MO; Stender M; Qizilbash N
    Clin Ther; 2008 Mar; 30(3):535-42. PubMed ID: 18405791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statin drugs and risk of advanced prostate cancer.
    Platz EA; Leitzmann MF; Visvanathan K; Rimm EB; Stampfer MJ; Willett WC; Giovannucci E
    J Natl Cancer Inst; 2006 Dec; 98(24):1819-25. PubMed ID: 17179483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statin Use and Risk of Atrial Fibrillation or Flutter: A Population-based Case-Control Study.
    Veronese G; Montomoli J; Schmidt M; Horváth-Puhó E; Sørensen HT
    Am J Ther; 2015; 22(3):186-94. PubMed ID: 23567792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
    Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
    Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HMG-CoA reductase inhibitors and the risk of vertebral fracture.
    Schoofs MW; Sturkenboom MC; van der Klift M; Hofman A; Pols HA; Stricker BH
    J Bone Miner Res; 2004 Sep; 19(9):1525-30. PubMed ID: 15312254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statin use and risk of first-time psoriasis diagnosis.
    Brauchli YB; Jick SS; Meier CR
    J Am Acad Dermatol; 2011 Jul; 65(1):77-83. PubMed ID: 21529997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association between statins and cancer incidence in a veterans population.
    Farwell WR; Scranton RE; Lawler EV; Lew RA; Brophy MT; Fiore LD; Gaziano JM
    J Natl Cancer Inst; 2008 Jan; 100(2):134-9. PubMed ID: 18182618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statins and prostate cancer risk: a case-control study.
    Shannon J; Tewoderos S; Garzotto M; Beer TM; Derenick R; Palma A; Farris PE
    Am J Epidemiol; 2005 Aug; 162(4):318-25. PubMed ID: 16014776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study.
    Boudreau DM; Gardner JS; Malone KE; Heckbert SR; Blough DK; Daling JR
    Cancer; 2004 Jun; 100(11):2308-16. PubMed ID: 15160333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative statin therapy is not associated with a reduced incidence of postoperative acute kidney injury after cardiac surgery.
    Argalious M; Xu M; Sun Z; Smedira N; Koch CG
    Anesth Analg; 2010 Aug; 111(2):324-30. PubMed ID: 20375302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.